These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26219896)

  • 41. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.
    Shimoda Y; Ubukata Y; Handa T; Yokobori T; Watanabe T; Gantumur D; Hagiwara K; Yamanaka T; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Harimoto N; Katayama A; Hikino T; Sano T; Ogata K; Kuwano H; Shirabe K; Oyama T
    BMC Cancer; 2018 May; 18(1):597. PubMed ID: 29801468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.
    Yun M; Rong J; Lin ZR; He YL; Zhang JX; Peng ZW; Tang LQ; Zeng MS; Zhong Q; Ye S
    Oncol Rep; 2015 Sep; 34(3):1397-405. PubMed ID: 26133271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TACC3 is an independent prognostic marker, and knockdown of TACC3 enhances the efficacy of CDK1 inhibitor RO3306 in liver cancer cells.
    Guo E; Yang J; Li L; Chen J; Liu H
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23402. PubMed ID: 37341435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
    Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
    Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
    Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
    Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.
    Mima K; Hayashi H; Imai K; Kuroki H; Nakagawa S; Okabe H; Chikamoto A; Watanabe M; Beppu T; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):429-34. PubMed ID: 23238743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency.
    Yokomichi N; Nishida N; Umeda Y; Taniguchi F; Yasui K; Toshima T; Mori Y; Nyuya A; Tanaka T; Yamada T; Yagi T; Fujiwara T; Yamaguchi Y; Goel A; Kudo M; Nagasaka T
    Liver Cancer; 2019 Jul; 8(4):239-254. PubMed ID: 31602368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
    Zen Y; Vara R; Portmann B; Hadzic N
    Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.
    Vasuri F; Golfieri R; Fiorentino M; Capizzi E; Renzulli M; Pinna AD; Grigioni WF; D'Errico-Grigioni A
    Virchows Arch; 2011 Aug; 459(2):141-6. PubMed ID: 21691816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
    Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
    Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
    Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
    Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic implications of ezrin expression in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Mol Carcinog; 2010 Sep; 49(9):798-804. PubMed ID: 20572160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
    Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
    Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.